Private Equity

Updated:

3H Health Investment Management

3H Health Investment Management was established as a healthcare venture capital firm. Its base spans Hong Kong and Shanghai. The firm concentrates on...

3H Health Investment Management logo

3H Health Investment Management

3H Health Investment Management was established as a healthcare venture capital firm. Its base spans Hong Kong and Shanghai. The firm concentrates on biotechnology and medical technology investments. The strategy covers early-stage seed and start-up rounds through expansion, late-stage and growth equity. Asset classes include private equity and venture commitments. Confirmed geographies center on Asia. The firm has executed deals in biotech platforms and related healthcare services. No public data exists on team size, additional vehicles or recent operational events within the last 24 months. The firm maintains a dedicated China focus that shapes its sourcing and portfolio construction relative to global healthcare funds.

General information

Firm type

Private Equity

Year founded

2016

Location

Region

Asia

Country

Hong Kong

City

Hong Kong

Corporate office

Hong Kong, Hong Kong

Additional offices

Shanghai

Sector focus

Digital HealthHealthcare ServicesBiotech

Frequently asked questions

Who runs investment decisions at 3H Health Investment Management?

No named principals or investment committee members appear in available sources.

What investment stages does 3H Health Investment Management target?

The firm covers early stage seed and start-up rounds, expansion, late stage and growth equity.

Which sectors does 3H Health Investment Management focus on?

Confirmed focuses include Digital Health, Healthcare Services and Biotech.

Does 3H Health Investment Management participate in fund commitments or only direct deals?

Available records list private equity and startup investments without specifying fund commitments versus direct deals.

Where does 3H Health Investment Management deploy capital geographically?

The firm concentrates on Asia with a stated emphasis on China.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Hong Kong Private Equity profiles